dr.dosingreferenceResearch Reference
← All articles
Timeline

NAD+ timeline: what research and user reports show

NAD+ is a coenzyme central to cellular energy production, and its reported timeline splits sharply by how it is used. Reports of an acute, felt effect during the dose itself are common, alongside a slower, cumulative energy change over weeks.

Not usage instructions. This is a summary of published research and publicly reported research community experience. It is not a protocol, not medical advice and not a recommendation to start, stop or adjust anything.

During the dose: acute reports

Flushing, chest tightness or a racing feeling during infusion or a fast injection are commonly reported, generally described as tied to the speed of administration rather than the total dose, with slower administration commonly associated with a milder acute response.

Weeks 1 to 4: cumulative energy reports

With regular use, reports increasingly describe steadier energy and mental clarity building over two to four weeks, described as more gradual and less dramatic than the acute in-dose sensations.

Common questions

Why does administration speed matter so much? Reports consistently associate faster administration with more pronounced acute sensations, which is part of why slower administration is commonly discussed as more tolerable.

For mechanism, dosing reference and citations, see the NAD+ reference page.

Putting this into practice? Browse the compound references or run your numbers in the dosage calculator.
Important. For research and educational use only. Not medical advice. Compounds referenced are for research use only and not for human consumption.